Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

» Details

Guru Trades

XBI Guru Trades in

Q1 2016

XBI Guru Trades in Q1 2016

First Eagle Investment 18,150 sh (New)
» More
Q2 2016

XBI Guru Trades in Q2 2016

Steven Cohen 191,000 sh (New)
First Eagle Investment 18,150 sh (unchged)
» More
Q3 2016

XBI Guru Trades in Q3 2016

Louis Moore Bacon 100,000 sh (unchged)
First Eagle Investment Sold Out
Steven Cohen 152,500 sh (-20.16%)
» More

Ratios

vs
industry
vs
history
P/B 4.89
XBI's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XBI: 4.89 )
Ranked among companies with meaningful P/B only.
XBI' s P/B Range Over the Past 10 Years
Min: 0  Med: 0 Max: 5.69
Current: 4.89
0
5.69

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.24
XBI's Dividend Yield is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XBI: 0.24 )
Ranked among companies with meaningful Dividend Yield only.
XBI' s Dividend Yield Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0.52
Current: 0.24
0
0.52
Yield on cost (5-Year) 0.25
XBI's Yield on cost (5-Year) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XBI: 0.25 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
XBI' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0.52
Current: 0.25
0
0.52

More Statistics

Short Percentage of Float0.00%
52-Week Range $44.16 - 69.21
Shares Outstanding (Mil)39,150,000.00
» More Articles for XBI

Headlines

Articles On GuruFocus.com
Weekly CEO Buys Highlight Jan 22 2017 
Nike's Pullback Is a Great Opportunity for Investors Jan 22 2017 
Cisco: A 10% Dividend Increase Could Be On the Way Jan 22 2017 
If You Think Intel Is Dead Money, Think Again Jan 22 2017 
AbbVie Gets FDA Approval for Lymphoma Drug Jan 22 2017 
Activision Blizzard Is Poised to Move Higher Jan 22 2017 
3 Great Stocks for Your 2017 Core Investment Portfolio Jan 22 2017 
BioCorRx Receives New Funding for Opioid Drug Jan 22 2017 
3M Could Increase Dividend by Up to 10% Jan 22 2017 
2018 Will Be IBM CEO Ginni Rometty’s Year of Vindication Jan 22 2017 

More From Other Websites
4 Top Biotech Mutual Funds for 2017 Jan 18 2017
Biotech ETFs: When Will The Pain End? Jan 17 2017
Biotech ETFs Continue To Bleed Jan 12 2017
Trump's First Press Conference Puts These ETFs in Focus Jan 12 2017
Trump's Remarks Show Why Pharma Sector Is 'Barely Investable': More Squawk From Jim Cramer Jan 12 2017
5 Things You Must Know Before the Market Opens Thursday Jan 12 2017
Donald Trump Whacks European Stocks Jan 12 2017
European Pharma Shares Hammered After Trump Press Conference Attack Jan 12 2017
Dow moves within 50 points of 20,000 after Trump news conference Jan 11 2017
Nasdaq Posts Another Record Close in Unpredictable Trump-Triggered Trading Session Jan 11 2017
P.M. Funds Roundup: Mexico, Biotech ETFs Get Trumped; Is It RIP For Bitcoin ETF? Jan 11 2017
Stocks Back to Gains in Unsettled Trade After Trump News Conference Jan 11 2017
Good Enough? Trump Outlines Plans to Separate From Business but Will Not Divest Holdings Jan 11 2017
Trump Takes Aim at Pharma but Investors Shouldn't Panic Jan 11 2017
Stocks Recover But Pharma Still Down After Trump's Threats Jan 11 2017
Biotech, Pharma ETFs Sink; Trump Promises "Bidding Procedures" Jan 11 2017
Biotech ETFs fall as Trump says more bidding needed on drugs Jan 11 2017
How Was Incyte’s Profitability in 3Q16? Jan 09 2017
The 'Super Bowl' for health care investors Jan 06 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK